As of Oct 06
| -1.72 / -1.73%|
The 18 analysts offering 12-month price forecasts for Gilead Sciences have a median target of 126.00, with a high estimate of 141.00 and a low estimate of 98.00. The median estimate represents a +29.18% increase from the last price of 97.54.
The current consensus among 22 polled investment analysts is to Buy stock in Gilead Sciences. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.